Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice

M. M. Hurley, Y. Okada, L. Xiao, Y. Tanaka, M. Ito, N. Okimoto, T. Nakamura, C. J. Rosen, Thomas C Doetschman, J. D. Coffin

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Since parathyroid hormone (PTH) increased FGF2 mRNA and protein expression in osteoblasts, and serum FGF-2 was increased in osteoporotic patients treated with PTH, we assessed whether the anabolic effect of PTH was impaired in Fgf2-/- mice. Eight-week-old Fgf2+/+ and Fgf2-/- male mice were treated with rhPTH 1-34 (80 μg/kg) for 4 weeks. Micro-CT and histomorphometry demonstrated that PTH significantly increased parameters of bone formation in femurs from Fgf2+/+ mice but the changes were smaller and not significant in Fgf2-/- mice. IGF-1 was significantly reduced in serum from PTH-treated Fgf2-/- mice. DEXA analysis of femurs from Fgf2+/+, Fgf2+/-, and Fgf2-/- mice treated with rhPTH (160 μg/kg) for 10 days showed that PTH significantly increased femoral BMD in Fgf2+/+ by 18%; by only 3% in Fgf2+/- mice and reduced by 3% in Fgf2-/- mice. We conclude that endogenous Fgf2 is important for maximum bone anabolic effect of PTH in mice.

Original languageEnglish (US)
Pages (from-to)989-994
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume341
Issue number4
DOIs
StatePublished - Mar 24 2006
Externally publishedYes

Fingerprint

Parathyroid Hormone
Bone
Bone and Bones
Anabolic Agents
Fibroblast Growth Factor 2
Femur
Osteoblasts
Insulin-Like Growth Factor I
Thigh
Serum
Osteogenesis
Messenger RNA
Proteins

Keywords

  • Bone formation
  • DEXA
  • Fgf2 haploinsufficient
  • Fgf2 null
  • Mice
  • Micro-CT
  • PTH

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Hurley, M. M., Okada, Y., Xiao, L., Tanaka, Y., Ito, M., Okimoto, N., ... Coffin, J. D. (2006). Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice. Biochemical and Biophysical Research Communications, 341(4), 989-994. https://doi.org/10.1016/j.bbrc.2006.01.044

Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice. / Hurley, M. M.; Okada, Y.; Xiao, L.; Tanaka, Y.; Ito, M.; Okimoto, N.; Nakamura, T.; Rosen, C. J.; Doetschman, Thomas C; Coffin, J. D.

In: Biochemical and Biophysical Research Communications, Vol. 341, No. 4, 24.03.2006, p. 989-994.

Research output: Contribution to journalArticle

Hurley, MM, Okada, Y, Xiao, L, Tanaka, Y, Ito, M, Okimoto, N, Nakamura, T, Rosen, CJ, Doetschman, TC & Coffin, JD 2006, 'Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice', Biochemical and Biophysical Research Communications, vol. 341, no. 4, pp. 989-994. https://doi.org/10.1016/j.bbrc.2006.01.044
Hurley, M. M. ; Okada, Y. ; Xiao, L. ; Tanaka, Y. ; Ito, M. ; Okimoto, N. ; Nakamura, T. ; Rosen, C. J. ; Doetschman, Thomas C ; Coffin, J. D. / Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice. In: Biochemical and Biophysical Research Communications. 2006 ; Vol. 341, No. 4. pp. 989-994.
@article{9de4b6405a91443f9dd9ddebd5524439,
title = "Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice",
abstract = "Since parathyroid hormone (PTH) increased FGF2 mRNA and protein expression in osteoblasts, and serum FGF-2 was increased in osteoporotic patients treated with PTH, we assessed whether the anabolic effect of PTH was impaired in Fgf2-/- mice. Eight-week-old Fgf2+/+ and Fgf2-/- male mice were treated with rhPTH 1-34 (80 μg/kg) for 4 weeks. Micro-CT and histomorphometry demonstrated that PTH significantly increased parameters of bone formation in femurs from Fgf2+/+ mice but the changes were smaller and not significant in Fgf2-/- mice. IGF-1 was significantly reduced in serum from PTH-treated Fgf2-/- mice. DEXA analysis of femurs from Fgf2+/+, Fgf2+/-, and Fgf2-/- mice treated with rhPTH (160 μg/kg) for 10 days showed that PTH significantly increased femoral BMD in Fgf2+/+ by 18{\%}; by only 3{\%} in Fgf2+/- mice and reduced by 3{\%} in Fgf2-/- mice. We conclude that endogenous Fgf2 is important for maximum bone anabolic effect of PTH in mice.",
keywords = "Bone formation, DEXA, Fgf2 haploinsufficient, Fgf2 null, Mice, Micro-CT, PTH",
author = "Hurley, {M. M.} and Y. Okada and L. Xiao and Y. Tanaka and M. Ito and N. Okimoto and T. Nakamura and Rosen, {C. J.} and Doetschman, {Thomas C} and Coffin, {J. D.}",
year = "2006",
month = "3",
day = "24",
doi = "10.1016/j.bbrc.2006.01.044",
language = "English (US)",
volume = "341",
pages = "989--994",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice

AU - Hurley, M. M.

AU - Okada, Y.

AU - Xiao, L.

AU - Tanaka, Y.

AU - Ito, M.

AU - Okimoto, N.

AU - Nakamura, T.

AU - Rosen, C. J.

AU - Doetschman, Thomas C

AU - Coffin, J. D.

PY - 2006/3/24

Y1 - 2006/3/24

N2 - Since parathyroid hormone (PTH) increased FGF2 mRNA and protein expression in osteoblasts, and serum FGF-2 was increased in osteoporotic patients treated with PTH, we assessed whether the anabolic effect of PTH was impaired in Fgf2-/- mice. Eight-week-old Fgf2+/+ and Fgf2-/- male mice were treated with rhPTH 1-34 (80 μg/kg) for 4 weeks. Micro-CT and histomorphometry demonstrated that PTH significantly increased parameters of bone formation in femurs from Fgf2+/+ mice but the changes were smaller and not significant in Fgf2-/- mice. IGF-1 was significantly reduced in serum from PTH-treated Fgf2-/- mice. DEXA analysis of femurs from Fgf2+/+, Fgf2+/-, and Fgf2-/- mice treated with rhPTH (160 μg/kg) for 10 days showed that PTH significantly increased femoral BMD in Fgf2+/+ by 18%; by only 3% in Fgf2+/- mice and reduced by 3% in Fgf2-/- mice. We conclude that endogenous Fgf2 is important for maximum bone anabolic effect of PTH in mice.

AB - Since parathyroid hormone (PTH) increased FGF2 mRNA and protein expression in osteoblasts, and serum FGF-2 was increased in osteoporotic patients treated with PTH, we assessed whether the anabolic effect of PTH was impaired in Fgf2-/- mice. Eight-week-old Fgf2+/+ and Fgf2-/- male mice were treated with rhPTH 1-34 (80 μg/kg) for 4 weeks. Micro-CT and histomorphometry demonstrated that PTH significantly increased parameters of bone formation in femurs from Fgf2+/+ mice but the changes were smaller and not significant in Fgf2-/- mice. IGF-1 was significantly reduced in serum from PTH-treated Fgf2-/- mice. DEXA analysis of femurs from Fgf2+/+, Fgf2+/-, and Fgf2-/- mice treated with rhPTH (160 μg/kg) for 10 days showed that PTH significantly increased femoral BMD in Fgf2+/+ by 18%; by only 3% in Fgf2+/- mice and reduced by 3% in Fgf2-/- mice. We conclude that endogenous Fgf2 is important for maximum bone anabolic effect of PTH in mice.

KW - Bone formation

KW - DEXA

KW - Fgf2 haploinsufficient

KW - Fgf2 null

KW - Mice

KW - Micro-CT

KW - PTH

UR - http://www.scopus.com/inward/record.url?scp=32344440164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32344440164&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2006.01.044

DO - 10.1016/j.bbrc.2006.01.044

M3 - Article

C2 - 16455048

AN - SCOPUS:32344440164

VL - 341

SP - 989

EP - 994

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 4

ER -